Tetra Tech, Inc. (NASDAQ:TTEK), a leading provider of high-end consulting and engineering services, announced today the pricing of $500.0 million aggregate principal amount of 2.25% Convertible Senior Notes due 2028 (the “notes”) in a private placement (the “offering”) only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Tetra Tech has also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $75.0 million aggregate principal amount of the notes. The sale of the notes to the initial purchasers is expected to close on August 22, 2023, subject to customary closing conditions.
PDS Biotech And National Cancer Institute Identify Optimal Patient Group For Advancing PDS0101-Based Triple Combination Program Targeting Advanced HPV-Positive Cancers
FLORHAM PARK, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer and
